Frequency of drug resistance in Plasmodium falciparum: A nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 914-919

  Gassis, Safwat ^a   Rathod, Pradipsinh K ^a  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; FLUOROOROTIC ACID;

ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG TOLERANCE; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0029916863     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.914     Document Type: Article

References (31)

1. Blanchard, T. J., D. C. Mabey, A. Hunt-Cooke, G. Edwards, D. B. A. Hutchinson, S. Benjamin, and P. L. Chiodini. 1994. Multiresistant falciparum cured using atovaquone and proguanil. Trans. R Soc. Trop. Med. Hyg. 88:693.
2. Bunnag, D., S. Malikul, S. Chittamas, D. Chindanond, T. Harinasuta, M. Fernex, M. L. Mittelholzer, S. Kristiansen, and D. Sturchler. 1992. Fansimef for prophylaxis of malaria, a double-blind randomized placebo controlled trial. Southeast Asian J Trop. Med. Public Health 23:777-782.
3. Canfield, C. J., M. Pudney, and W. E. Gutteridge. 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80:373-381.
4. Desjardins, R. E. 1984. In vitro techniques for antimalarial development and evaluation Handb. Exp Phamiacol. 68:179-206.
5. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979 Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique Antimicrob Agents Chemother. 16:710-718
6. Fry, M., and M. Pudney. 1992. Site of action of the antimalarial hydroxynaphthoquinone 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy1,4-naphthoquinone (566C80). Biochem Pharmacol. 43:1545-1553
7. Górner, Z. M., and P. K. Rathod. 1990. Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice. Antimicrob Agents Chemother. 34:1371-1375.
8. Hammond, D. J., J. R. Burchell, and M. Pudney. 1985. Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinonc in vitro. Mol. Biochem. Parasitol 14: 97-109
9. Haynes, J. D., C. L. Diggs, F. A. Hines, and R. E. Desjardins. 1976. Culture of human malarial parasite, Plasmodium falciparum. Nature (London) 263: 767-769
10. Hitchings, G. H. 1960. Pyrimethamine the use of an antimetabolite in the chemotherapy of malaria and other infections. Clin Pharmacol. Ther. 1:570-589.
11. Hudson, A. T. 1993. Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol. Today 9:66-68.
12. Hudson, A. T., M. Dickins, C. D. Ginger, W. E. Gutteridge, T. Holdich, D. B. A. Hutchinson, M. Pudney, A. W. Randall, and V. S. Latter. 1991. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp. Clin. Res. 17:427-435.
13. Hudson, A. T., A. W. Randall, M. Fry, C. D. Ginger, B. Hill, V. S. Latter, N. McHardy, and R. B. Williams. 1985. Novel antimalarial hydroxynaphthoquinones with potent broad spectrum antiprotozoal activity. Parasitology 90:45-55.
14. Ittarat, I., W. Asawamahasakda, and S. R. Meshnick. 1994. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Exp. Parasitol. 79:50-56.
15. Looareesuwan, S., P. Wilairatana, S. Vanijanonta, A. Kyle, and K. Webster. 1992. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet 339:369.
16. Milhous W. K., N. F. Weatherly., J. H. Bowdre, and R. E. Desjardins. 1984. Interaction of mefloquine and a fixed concentration of sulfadoxine and pyrimethamine (Fansidar) against Plasmodium falciparum in vitro, p. 112. In Proceedings of the 11th International Congress of Tropical Medicine and Malaria, Calgary. Elsevier Science Publishing, Inc., New York.
17. Oaks, S. C., Jr., V. S. Mitchell, G. W. Pearson, and C. C. J. Pearson (ed.). 1991. Malaria. Obstacles and opportunities. National Academy Press, Washington, D.C.
18. Oduola, A. M. J., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1985 Plasmodium falciparum: cloning by single erythrocyte manipulation and heterogeneity in vitro. Exp Parasitol. 66:86-95.
19. Peters, W. 1990. The prevention of antimalarial drug resistance. Pharmacol. Ther. 47:499-508.
20. Pfefferkorn, E. R., S. E. Borotz, and R. F. Nothnagel. 1993. Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate. J. Parasitol. 79:559-564.
21. Rahman, N. A., and D. C. Warhurst. 1985. Drug synergism against Plasmodium falciparum in vitro. Trans. R. Soc Trop. Med Hyg. 79:279
22. Rathod, P. K., and Z. M. Gomez. 1991. Plasmodium yoelii: oral delivery of 5-fluoroorotate to treat malaria in mice. Exp. Parasitol. 73:512-514.
23. Rathod, P. K., A. Khatri, T. Hubbert, and W. K. Milhous. 1989 Selective activity of 5-fluoroorotic acid against Plasmodium falciparium in vitro. Antimicrob Agents Chemother. 33:1090-1094
24. Rathod, P. K., M. Khosla, S. Gassis, R. D. Young, and C. Lutz. 1994. Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 38:2871-2876.
25. Rathod, P. K., N. P. Leffers, and R. D. Young. 1992. Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum. Antimicrob. Agents Chemother. 36:704-711.
26. Rathod, P. K., and S. Reshmi. 1994. Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase Antimicrob. Agents Chemother. 38:476-480.
27. Salako, L. A., R. A. Adio, O. Walker, A. Sowunmi, D. Sturchler, M.-L. Mittelholzer, R. Reber-Liske, and U. Dickschat. 1992. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum. a double-blind, comparative, placebo-controlled study. Ann. Trop. Med. Parasitol. 86:575-581.
28. Seymour, K. K., S. D. Lyons, L. Phillips, K. H. Rickmann, and R. I. Christopherson. 1994. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry 33:5268-5274.
29. Trager, W., and J. B. Jensen. 1978. Human malaria parasites in continuous culture Science 193:673-675.
30. Wu, Y., C. D. Sifri, H.-H. Lei, X.-Z. Su, and T. E. Wellems. 1995 Transfection of Plasmodium falciparum within human red blood cells Proc. Natl Acad. Sci. USA 92:973-977.
31. Young, R. D., and P. K. Rathod. 1993. Clonal viability measurements on Plasmodium falciparum to assess in vitro schizonticidal activity of leupeptin, chloroquine, and 5-fluoroorotate. Antimicrob. Agents Chemother. 37:1102-1107